Home Valuable stamps Brokerages Expect Stamps.com Inc. (NASDAQ: STMP) to Post Quarterly Sales of $ 197.78 million

Brokerages Expect Stamps.com Inc. (NASDAQ: STMP) to Post Quarterly Sales of $ 197.78 million


Brokerages expect Stamps.com Inc. (NASDAQ: STMP) to report $ 197.78 million in sales for the current fiscal quarter, Zack reports. Two analysts have released earnings estimates for Stamps.com. The lowest sales estimate is $ 194.66 million and the highest is $ 200.90 million. Stamps.com reported sales of $ 206.73 million in the same quarter last year, suggesting a negative 4.3% year-over-year growth rate. The company is expected to announce its next quarterly earnings report on Thursday, August 5.

On average, analysts expect Stamps.com to report annual sales of $ 787.81 million for the current year, with estimates ranging from $ 775.20 million to $ 800.42 million. . For the next fiscal year, analysts predict the company will post sales of $ 856.27 million, with estimates ranging from $ 821.30 million to $ 891.24 million. Zacks sales averages are an average based on a survey of analysts who track Stamps.com.

Stamps.com (NASDAQ: STMP) last reported its quarterly results on Thursday, May 6. The software maker reported EPS of $ 2.08 for the quarter, beating the consensus estimate of $ 1.69 by $ 0.39. The company posted revenue of $ 189.10 million for the quarter, compared to analysts’ estimates of $ 190.07 million. Stamps.com reported a return on equity of 25.32% and a net margin of 24.68%. The company’s revenue for the quarter increased 24.9% year-over-year. In the same quarter of last year, the company posted earnings per share of $ 1.32.

Separately, Zacks investment research upgraded Stamps.com from a “strong selling” rating to a “conservation” rating in a research report Thursday.

In other Stamps.com news, CMO Sebastian Buerba sold 2,511 shares of the company in a trade dated Tuesday, July 6. The stock was sold for an average price of $ 200.69, for a total value of $ 503,932.59. After the sale closes, the chief marketing officer now owns 2,511 shares of the company, valued at $ 503,932.59. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In addition, insider Amine Khechfe sold 4,959 shares of the company in a transaction dated Tuesday, July 6. The stock was sold for an average price of $ 200.00, for a total value of $ 991,800.00. After the sale closes, the insider now directly owns 5,306 shares of the company, valued at approximately $ 1,061,200. Disclosure of this sale can be found here. In the past ninety days, insiders have sold 17,272 shares of the company valued at $ 3,429,961. 6.53% of the shares are held by insiders.

A number of hedge funds and other institutional investors have recently changed their holdings to STMP. Los Angeles Capital Management LLC increased its stake in Stamps.com shares by 14.3% during the fourth quarter. Los Angeles Capital Management LLC now owns 20,169 shares of the software maker valued at $ 3,957,000 after purchasing an additional 2,525 shares during the period. SkyOak Wealth LLC increased its stake in Stamps.com shares by 20.7% during the first quarter. SkyOak Wealth LLC now owns 2,707 shares of the software maker valued at $ 578,000 after purchasing an additional 465 shares during the period. Alliancebernstein LP increased its holdings of Stamps.com shares by 1.6% in the first quarter. Alliancebernstein LP now owns 28,079 shares of the software maker valued at $ 5,602,000 after purchasing an additional 450 shares during the period. Livingston Group Asset Management CO operating as Southport Capital Management acquired a new stake in Stamps.com shares during the first quarter valued at approximately $ 1,459,000. Finally, BlackRock Inc. increased its holdings of Stamps.com shares by 2.3% during the first quarter. BlackRock Inc. now owns 2,886,212 shares of the software maker valued at $ 575,828,000 after purchasing an additional 65,775 shares during the period. 85.55% of the shares are held by institutional investors and hedge funds.

Shares of Stamps.com opened at $ 324.23 on Monday. The stock has a market cap of $ 5.94 billion, a price-to-earnings ratio of 32.01 and a beta of 0.34. Stamps.com has a 12-month low of $ 159.22 and a 12-month high of $ 325.13. The company’s fifty-day moving average price is $ 194.69.

Company Profile Stamps.com

Stamps.com Inc provides Internet mail and shipping solutions in the United States and Europe. It operates in two segments, Stamps.com and Metapack. The company provides courier and shipping solutions for posting and shipping various couriers and packages through the United States Postal Service (USPS) under the Stamps.com, Endicia, Metapack, ShippingEasy, ShipEngine, ShipStation and ShipWorks brands.

Featured Article: How is a Moving Average Calculated?

Get a free copy of the Zacks Research Report at Stamps.com (STMP)

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured article: What does an equal weight rating mean?

7 health actions serving innovation in 2021

We all knew that traditional health services were disrupted in 2020. The patient-doctor relationship has gone virtual. During the first months of the pandemic, many people in need of elective surgeries simply did not have this option available to them. And even local pharmacies have taken on a new role in e-commerce as curbside pickup or home delivery of prescription drugs has become the norm.

It’s no surprise that healthcare stocks took a rough ride last year. Overall, the sector was down 11%, well below the S&P 500 which climbed more than 15%.

However, the market is always looking to the future with a particular eye on innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in the advanced testing phase for drugs that can deliver groundbreaking results for conditions that continue to plague our world.

This is the object of this presentation. We have identified 7 healthcare actions that offer innovative ideas that will help achieve better patient outcomes. And in some cases, it will completely revolutionize medicine. These are also the stocks that analysts watch.

Consult the “7 healthcare stocks for innovation in 2021”.